David Sommerhalder
Impact in
-
- Cancer Immunotherapy and Biomarkers
-
- Methemoglobinemia and Tumor Lysis Syndrome
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 24
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 5
- Colorectal Cancer Treatments and Studies 5
- Co-authors
- Prakash Peddi (1 shared paper)Amol Takalkar (1 shared paper)Rodney E. Shackelford (1 shared paper)Manish Sharma (4 shared papers)David S. Hong (5 shared papers)Minal Barve (5 shared papers)Noboru Yamamoto (4 shared papers)Allison Reed (1 shared paper)
- Journals
- Journal of Clinical Oncology (20 papers)Annals of Oncology (7 papers)Cancer Research (6 papers)Journal of Thoracic Oncology (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesJapanChina
In The Last Decade
David Sommerhalder
38 papers receiving 154 citations
Peers
Comparison fields: 5 of 28
- Oncology 66
- Pulmonary and Respiratory Medicine 47
- Immunology 29
- Molecular Biology 89
- Hepatology 10
Countries citing papers authored by David Sommerhalder
This map shows the geographic impact of David Sommerhalder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sommerhalder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sommerhalder more than expected).
Fields of papers citing papers by David Sommerhalder
This network shows the impact of papers produced by David Sommerhalder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sommerhalder. The network helps show where David Sommerhalder may publish in the future.
Co-authors
The 25 scholars most cited alongside David Sommerhalder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 22 | |
| 2 | 2025 | 14 | |
| 3 | 2021 | 10 | |
| 4 | 2024 | 9 | |
| 5 | 2022 | 9 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 7 | |
| 8 | 2024 | 6 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2021 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2023 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2019 | 3 | |
| 20 | 2023 | 3 |
About David Sommerhalder
David Sommerhalder is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Immunology, having authored 43 papers that have together received 162 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Cancer Genomics and Diagnostics (7 papers), CAR-T cell therapy research (6 papers), Cancer Research and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Oncology (66 citations), Pulmonary and Respiratory Medicine (47 citations), Immunology (29 citations), Molecular Biology (89 citations) and Hepatology (10 citations). David Sommerhalder has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Prakash Peddi, Amol Takalkar, Rodney E. Shackelford, Manish Sharma, David S. Hong, Minal Barve, Noboru Yamamoto, Allison Reed, Scott Boiko and Jill M. Mooney. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Journal of Thoracic Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.